Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
For best results when printing this announcement, please click on link below: Alkermes to Present New Data on Alixorexton and LUMRYZ(®) (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research — Data From Vibrance-1 Phase 2 Study Lancet Neurology Publication Evaluating Alixorexton in Na